Anzeige
Mehr »
Login
Donnerstag, 20.02.2020 Börsentäglich über 12.000 News von 619 internationalen Medien
Nach 240 % Plus- Neue Empfehlung! Die Revolution der Gold und Cannabisbranche!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12B8E ISIN: IE00BQPVQZ61 Ticker-Symbol: HPR 
Tradegate
19.02.20
19:10 Uhr
33,600 Euro
+0,400
+1,20 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
HORIZON THERAPEUTICS PLC Chart 1 Jahr
5-Tage-Chart
HORIZON THERAPEUTICS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
33,400
33,600
08:03
33,400
33,600
08:03

Aktuelle News zur HORIZON THERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiHorizon Therapeutics plc Announces U.S. FDA Approval of New Dosage Form for PROCYSBI (Cysteamine Bitartrate) Delayed-Release Oral Granules1.388-- Oral granules in packets provide an additional, tear-open option for people living with cystinosis -- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that the U.S. Food and Drug Administration...
► Artikel lesen
11.02.Uplifting Athletes Announces Horizon Therapeutics plc as Exclusive Sponsor to Help Tackle Rare Disease at the National Football League (NFL) Scouting Combine99-- NFL Draft Prospects Participating in 'Reps for Rare Disease' Will Help Raise Funds for Research and Awareness Programs -- -- Horizon will match Pledged Donations Through the Company's...
► Artikel lesen
HORIZON THERAPEUTICS Aktie jetzt für 4€ handeln
04.02.Horizon Therapeutics USA, Inc. -- Moody's revises Horizon Therapeutics' outlook to positive; affirms Ba3 CFR2
04.02.Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2019 Financial Results and Host Webcast on Feb. 26, 2020117Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its fourth-quarter and full-year 2019 financial results will be released on Wednesday, Feb. 26, 2020. Following the announcement, Horizon's...
► Artikel lesen
28.01.Horizon Therapeutics Announces Significant Expansion and Relocation of U.S. Operations235Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has agreed to purchase the three-building campus in Deerfield that formerly belonged to Takeda Pharmaceuticals. The transaction is expected...
► Artikel lesen
24.01.Horizon Therapeutics plc Announces Changes in Research and Development Organization362Scott Brun, M.D. Named Senior R&D Advisor Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure. Effective immediately, Elizabeth...
► Artikel lesen
23.01.Horizon Therapeutics Gets FDA Approval for Eye Drug2
23.01.Genmab A/S: Horizon Therapeutics Secures U.S. FDA Approval for Teprotumumab, for the Treatment of Thyroid Eye Disease (TED)12
22.01.Horizon Therapeutics Gets FDA Approval for Eye Drug Tepezza2
22.01.Biotech Stock Roundup: Updates From HZNP & CLVS, BioNTech to Acquire Neon63
22.01.The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings2
21.01.Horizon Therapeutics Public Ltd Co - 8-K, Current Report1
16.01.Horizon Therapeutics (HZNP) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow-
14.01.HORIZON THERAPEUTICS USA, INC -- Moody's announces completion of a periodic review of ratings of Horizon Therapeutics USA, Inc.1
13.01.Horizon Therapeutics plc Increases Peak U.S. Annual Net Sales Expectations for Key Growth Drivers; Provides Update on Several Pipeline Programs166-- Increases KRYSTEXXA (pegloticase injection) Peak U.S. Annual Net Sales Expectations to More Than $1 Billion -- -- Increases Teprotumumab Peak U.S. Annual Net Sales Expectations to More...
► Artikel lesen
13.01.Horizon Therapeutics Public Ltd Co - 8-K, Current Report-
10.01.Horizon Therapeutics: Looking Solid In 20202
03.01.Horizon Therapeutics' Stock Up in a Year on Pipeline Progress3
18.12.19Horizon Therapeutics Public Ltd Co - 8-K, Current Report3
18.12.19Horizon Therapeutics Rally May Be Short-Lived As Investors Wait For Key Date In March5
Seite:  Weiter >>
78 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1